On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Introduction (2)
- Problems with current risk factors
- Effects of risk factors on CVD mortality
- Prediction of CHD in diabetes
- Oxidative stress and cardiovascular risk
- Molecular consequences of oxidative stress
- The polygenic nature of CHD
- Gene environment interaction
- Genes load the gun, environment pulls the trigger
- Genetic & biochemical markers of oxidative stress
- Aim of this presentation
- Measurement of oxidative stress
- Plasma Total Antioxidant Status (TAOS)
- Mitochondrial uncoupling protein 2
- A novel antioxidant UCP2 ?
- Mitochondria are major source of cellular ROS
- UCL-diabetes and cardiovascular disease study
- Northwick park heart study II
- Prospective CHD risk by plasma TAOS in NPHSII
- UCP2 common variants
- Plasma TAOS and UCP2 -866G>A genotype
- Oxidative stress and UCP2 -866G>A genotype
- Plasma TAOS, smoking, and UCP2 -866G>A
- UCP2 genotype and CHD risk in NPHSII
- Other CHD risk factors
- The important of UCP2
- UCP2 environment interaction and CHD risk
- Does statin treatment reduce oxidative stress?
- Apolipoprotein E (APOE)
- APOE and CHD risk
- APOE genotype and CHD risk
- APOE and oxidative stress
- The APOE genotype interaction with smoking
- Glutathione s-transferase gene (GST)
- GSTs and oxidative stress
- The role of glutathione s-transferase
- GST gene variants
- GST gene variants and CVD
- Plasma Ox-LDL by GSTT1 genotype & smoking
- Other gene variants (1)
- Other gene variants (2)
- Summary overview
- Acknowledgments
Topics Covered
- Oxidative stress: a risk factor for CVD
- Biochemical markers of oxidative stress
- Genetic determinants of oxidative stress: examples
- Examples of gene-environment interaction in determining oxidative stress and CVD
- Other gene variants and oxidative stress
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Stephens, J. (2008, November 24). Gene-environment interaction and oxidative stress in cardiovascular disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/QYWF3240.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Jeffrey Stephens has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Gene-environment interaction and oxidative stress in cardiovascular disease
A selection of talks on Clinical Practice
Hide